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Abstract
The pathogenesis of Japanese encephalitis virus (JEV) is not definitely elucidated as the initial interaction between
virus and host cell receptors required for JEV infection is not clearly defined yet. Here, in order to discover those
membrane proteins that may be involved in JEV attachment to or entry into virus permissive BHK-21 cells, a
chemically mutated cell line (designated 3A10-3F) that became less susceptible to JEV infection was preliminarily
established and selected by repeated low moi JEV challenges and RT-PCR detection for viral RNA E gene fragment.
The susceptibility to JEV of 3A10-3F cells was significantly weakened compared with parental BHK-21 cells, verified
by indirect immunofluorescence assay, virus plague formation assay, and flow cytometry. Finally, two-dimensional
electrophoresis (2-DE) coupled with LC-MS/MS was utilized to recognize the most differentially expressed proteins
from membrane protein extracts of 3A10-3F and BHK-21 cells respectively. The noted discrepancy of membrane
proteins included calcium binding proteins (annexin A1, annexin A2), and voltage-dependent anion channels
proteins (VDAC 1, VDAC 2), suggesting that these molecules may affect JEV attachment to and/or entry into BHK-
21 cells and worthy of further investigation.
Findings
Japanese encephalitis virus (JEV), a member of genus
Flavivirus in the family Flaviviridae, is the causative
agent of Japanese encephalitis (JE), the mosquito-borne
viral encephalitis epidemic in eastern, southeastern and
southern Asia, leading to an estimated ~50,000 infec-
tions annually, of which ~15,000 will die and up to 50%
of survivors are left with severe residual neurological
complications [1,2]. During the past decades, JE is
spreading beyond its traditional boundaries and has
reported from previously unaffected areas such as
Saipan islands, Pakistan and northern Australia [3-5].
Coupled with a high rate of mortality and residual neu-
rological complications in survivors, it makes JE a ser-
ious public health problem in tropical and subtropical
areas in the world.
The first step of virus infection requires the interaction
between virus attachment proteins (VAPs) and cellular
receptors, which is known to contribute to host range,
tissue tropism and viral pathogenesis. In the cases of fla-
viviruses including JEV, envelope glycoprotein E, pro-
t r u d i n ga ss p i k e so nt h es u r f a c e of virions, is considered
to be the dominant antigen in mediating receptor binding
and membrane fusion, hemagglutination, neutralization
and virulence [6-8]. As of enzootic nature, JEV maintains
a natural cycle among birds, pigs, and other vertebrate
hosts by mosquitoes without serious sickness, and thus
the cells from above species, such as African green mon-
key kidney cells (Vero), baby hamster kidney cells (BHK-
21), and Aedes albopictus cells (C6/36) [9], are frequently
applied in studies associated with JEV pathogenicity due
to their ability to permit JEV entry and replication within
them. Such broad tropism of JEV rationally suggests that
most possibly there exists more than one cellular recep-
tor responsible for virus binding and entry into suscepti-
ble cells above mentioned.
To date, little is known about JEV cellular receptors.
Much earlier, a report stated that a 74 kDa protein on
Vero cells was found to be capable of binding JEV and
might be involved in virus uptake process [10]. A recent
paper also indicated that several proteins on the surface
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150-200 kDa may bind to JEV, but failed to identify spe-
cific proteins by mass spectroscopic fingerprint analysis
[11]. In 2009, a paper reported that heat shock protein
70 is a putative receptor for JEV on mouse neuroblas-
toma (Neuro2a) cells [12]. Hence, the detailed interac-
tion between JEV and its putative receptor(s) is not
exclusively defined yet.
One of the most convincing methods to verify a putative
virus receptor is to transfer the receptor gene into a cell
line that cannot bind virus and later demonstrate that the
receptor-negative cell acquires the ability to bind virus and
permit virus to replicate within it after the receptor gene is
regained [13]. For this reason, the availability of a specific
virus receptor-negative/-defective cell line is usually a pre-
requisite for virus receptor confirmation. Unfortunately,
such JEV receptor-negative/-defective cell line is not cur-
rently available after our extensive searching for animal
and human cell lines, and thus it has to be established
artificially.
The successful identification of the cellular receptor
for anthrax toxin provided us a practical strategy to cre-
ate any specific virus receptor-negative/-defective cells
[14]. Here, BHK-21 cells, permissive to JEV entry and
replication, were subject to co-culture with a DNA alky-
lating mutagen ICR-191 to introduce random small
DNA deletions and frame shift mutations in the genes
of normally cultured BHK-21 cells under conditions that
led to ~90% cell death. The survived cells were grown
up but underwent a slow die-off for 4 weeks. These
viable but mutated BHK-21 cells were successively sub-
ject to several rounds of infectious JEV challenge at a
low moi of 0.1, subcloned by limiting dilution, and then
each individual subclones was detected by RT-PCR for
negative JEV E gene RNA fragment. RT-PCR primers
were synthesized according to the RNA sequence of JEV
SA-14 strain [15] from 1528 to 2234 of E gene con-
served fragment, which were sense-strand primer,
5’-CGGAATTCGAGAAGTCACACTGGACTGTGA
GCC-3’, and antisense-strand primer, 5’-CGCTGC
CAGTC TTTGAGCTCCCTTCAAAGT-3’. Finally, such
a JEV RNA-negative mutated cell line, designated 3A10-
3F, was picked out after two cycles of limiting dilution
cloning from eight subclones of mutated BHK-21 cells
(Figure 1). Further, the susceptibility of 3A10-3F to JEV
infection was tested by indirect immunofluorescence
assay (IFA), viral plaque formation assay, and flow cyto-
metry. In IFA, JEV E protein synthesized within the
cells was detected by monoclonal antibody against E
protein. The results clearly displayed that fluorescent
signals from 3A10-3F were much weaker (Figure 2b)
than BHK-21 cells (Figure 2d) with the same dosage of
JEV, while both negative controls of the two cell lines
appeared the same (Figure 2a and Figure 2c).
To reckon the susceptibility of 3A10-3F to JEV, virus
plaque formation assay and flow cytometry were applied.
It appeared that JEV was able to replicate in the same
kinetic mode in either 3A10-3F or BHK-21 cells at
0-48 h post-infection (Figure 3), but the numbers of
infectious virions detected by plaque formation assay in
3A10-3F cells were remarkably declined. At moi of 1, the
h i g h e s tJ E Vt i t e ra t4 8hp o s t - i n f e c t i o nf r o m3 A 1 0 - 3 F
cells was decreased by 2 orders of logarithm compared
with that of titer from BHK-21 cells (Figure 3a). At moi
of 10, the highest titer from 3A10-3F cells was lowered
by 1 order of logarithm compared with that of from
BHK-21 cells. Conspicuously there was a similar decline
mode of virus replication in 3A10-3F cells compared
with its parental cells between the two moi of JEV.
In flow cytometry, the binding between 3A10-3F cells
and JEV was 2.10% (Figure 4a), much lower than the bind-
ing between BHK-21 cells and JEV (48.84%, Figure 4b),
clearly indicating that 3A10-3F cells are defective of JEV
binding because of the compromise of normal surface pro-
tein functioning for JEV attachment and/or entry. Besides,
3A10-3F cells appear morphologically similar (Figure 5a)
to normal BHK-21 cells (Figure 5c), and still susceptible to
HSV-1 (SM64 strain) infection as they manifested the
similar CPEs (Figure 5b) as rapidly as BHK-21 cells did
(Figure 5d). The reason to choose HSV-1 is that HSV
binds to its surface protein molecules definitely different
from that of JEV on BHK-21 cells, thus excluding the pos-
sibility that several mosquito-borne flaviviruses (such as
JEV, Dengue virus, West Nile virus, etc) may attach the
same protein molecules when virus-host interaction
occurs [16]. Therefore, the HSV-1 infection test reinforced
that resistance of 3A10-3F cells to JEV infection was speci-
fic for JEV (machinery for gene expression appeared
Figure 1 Selection of mutated cell lines negative of JEV E gene
RNA fragments by RT-PCR. Eight single-cell clones of mutated
cells (lanes 4-11) were detected in triplicate. The arrow indicates 707
bp fragments containing the conserved JEV E gene sequence. Only
one single-cell clone, designated 3A10-3F, showed JEV RNA
negative (lane 8). BHK-21 cells (lane 1) and BHK-21 cells infected
with JEV (lane 2) were negative and positive controls respectively.
Lane 3 was DL-2000 DNA marker.
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decreased virus replication within the cells but from less
virus binding to cell surface molecules necessary for JEV
attachment and/or entry.
All data above implied that (i) JEV was still permissive to
replicate within 3A10-3F cells but at a low level; (ii) JEV
might enter 3A10-3F cells through different molecule
routes, possibly high affinity and low affinity receptors
[10]; and (iii) 3A10-3F cells became resistant to JEV infec-
tion most likely due to the altered surface protein expres-
sion after chemical mutagenesis rather than the mutations
of certain intracellular factors essential for JEV replication.
Finally, two-dimensional electrophoresis (2-DE) coupled
with mass spectrometry was used to determine those
differentially expressed proteins between 3A10-3F and
BHK-21 cell membrane protein extracts following Mirza’s
method [17]. Altogether 23 spots of differentially
expressed proteins on SDS-PAGE gels were picked out
(Figure 6) upon computerized sifting criteria (the smooth
parameter was set to a value of 2; the minimum area was
above 8 pixels; the saliency parameter was experimentally
adjusted to 1), including six up-regulated spots (11, 12, 14,
17, 19, 21) and six down-regulated spots (1, 4-7, 9) in
3A10-3F cells compared with BHK-21 cells, seven spots
(13, 15, 16, 18, 20, 22, 23) solely expressed in 3A10-3F
cells and four spots (2, 3, 8, 10) in BHK-21 cells respec-
tively. These spots were subject to mass spectrometry ana-
lysis in combination with a mouse peptide database
Figure 2 JEV binding to 3A10-3F and BHK-21 cells measured by indirect immunofluorescence assay (IFA). JEV antigen were detected
with anti-JEV mAb and FITC-conjugated goat anti-mouse IgG at 24 hr post-infection, and uninfected 3A10-3F cells (a) and BHK-21 cells (c) were
negative controls. The cytoplasm and nuclei were stained red by Evans blue, and green fluorescent signals of viral antigen were significantly
weaker in 3A10-3F cells (b) than in BHK-21 cells (d) (Magnification: ×400).
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among the 23 samples (spots 1, 3-5, 7, 10-12, 14-16, 20,
22, and 23) were determined with good peptide coverage
and significant scoring (Additional file 1 table S1). Not
surprisingly, not all proteins extracted were membrane
proteins, but all proteins with most altered abundance
must have been disclosed. With such certitude, four mem-
brane proteins from 3A10-3F cells recognized by mass
spectrometry, annexin 1 and annexin 2, voltage-dependent
anion channel (VDACs) 1 and 2, were of our particular
interests.
A n n e x i n sa r eaf a m i l yo fs t r u c t u r a l l yr e l a t e dp r o t e i n s
whose common properties are to bind both phospholi-
pids and cellular membranes in a calcium-dependent
manner [18]. Annexin 1 involves in diverse cellular
roles, including membrane fusion, exocytosis, differen-
tiation, apoptosis, calcium channels, inflammatory reac-
tions, and interaction with cytoskeletal proteins [19]. To
date, few but one report [20] referred the role of
annexin 1 in viral infection, stating that infectious pan-
creatic necrosis virus (IPNV) infection to fish cell
increased the expression of salmon annexin 1, and the
Figure 3 JEV replication in 3A10-3F (black trianle) and BHK-21 (black square) cells measured by plaque formation assay. Cells were
infected with JEV at moi of 1 (a) and 10 (b). The viral titers were determined by plaque formation assay for culture supernatant samples
harvested at 0, 12, 24, 36, and 48 hr post-infection. The numbers of virions detected in 3A10-3F cells was greatly reduced. The results displayed
were the means of independent experiments performed in duplicate.
Figure 4 JEV binding to 3A10-3F and BHK-21 cells measured by flow cytometry. Cells were incubated with JEV for 1 hr and were stained
with rabbit anti-JEV antibodies followed by FITC-conjugated goat anti-rabbit IgG. Limited binding of JEV to 3A10-3F cells was shown (2.10%, a),
whereas JEV significantly bound BHK-21 cells (48.84%, b).
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apoptosis of IPNV-infected cells and supported the
growth of IPNV in cells. In addition, annexin 2 had
been identified as a receptor for cytomegalovirus (CMV)
and respiratory syncytial virus (RSV) [21,22], and also
promoted entry of HIV-1 into cells and proper assembly
of HIV-1 in cells [23,24]. In our study, the expression of
annexin 1 and annexin 2 were found to be significantly
reduced on 3A10-3F cells, possibly suggesting that they
may be involved in JEV attachment and/or entry.
VDACs is a multigene family of evolutionarily con-
served and well characterized porins found in outer
mitochondrial membranes of all eukaryotes [25], where
they control homeostasis by transport of ATP and
ADP [26]. Numerous research groups also reported the
presence of VDAC proteins in the plasma membrane
of various cell types [27,28]. VDAC 1 contributed to
ATP transport across the plasma membrane of murine
cells [29], and could act as NADH-ferricyanide reduc-
tase to inhibit the release of synthesized ATP and
greatly decrease the activity of exogenous NADH/cyto-
chrome-c system of intact mitochondria [30], however
the significance of its total absence from 3A10-3F on
JEV infection is not reported. Mammalian VDAC 2
exhibited other more biological activities, such as
interaction with Bcl-2 family proteins, critical regula-
tors of apoptosis [31]. In our study, VDAC 2 should
not be a candidate for JEV binding molecule as it dis-
played an increased expression (16-fold) on 3A10-3F
cells.
Nevertheless, some membrane molecules other than
annexins and VDACs may not be excluded to mediate
JEV entry into cells. It is not unusual that a virus particle
utilizes multiple surface proteins during cell entry
[32-34]. Several viruses utilize at least two different mole-
cules to interact with their host cells via: (i) the binding
receptors, merely serve as attachment factors that con-
centrate or recruit viruses on cell surface; (ii) co-recep-
tors, that are used by the virus after binding to the cells,
not only bind viruses but are also responsible for direct-
ing the bound viruses into endocytic pathways and for
transmitting followed signals to the cytoplasm [35].
Taken together, the mutated cell line 3F10-3F from
parental BHK-21 cells became less susceptible to JEV
Figure 5 Cell morphology and CPEs of 3A10-3F and BHK-21 cells under a phase-contrast microscope. 3A10-3F cells (a) appeared
morphologically similar to parental BHK-21 cells (c). After infected with HSV-1, 3A10-3F cells (b) appeared similar CPEs to normal BHK-21 cells
infected with HSV-1(d) (Magnification: ×200).
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between daughter and parental cells thus provides
important clues to further investigate the individual role
of the membrane proteins in JEV infection on BHK
cells.
Additional material
Additional file 1: Table 1: Comparison of LC-MS/MS recognized
proteins between 3A10-3F and BHK-21 cells. A wider table describing
recognized protein properties in MS Word .doc format.
Figure 6 Representative 2-DE maps of 3A10-3F and BHK-21 cell membrane protein extracts. Membrane proteins from 3A10-3F (a) and
BHK-21 cells (b) were separated by 2-DE and stained with sliver. 23 most differentially expressed protein spots were marked with arrows, and
these spots were analyzed by LC-MS/MS. Three separate gels were prepared for each cell line.
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BHK: baby hamster kidney; CPE: cytopathic effect; FITC: fluorescein
isothiocyanate; HSV: herpes simplex virus; IFA: indirect immunofluorescence
assay; ICR-191: (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-
methoxyacridine; JEV: Japanese encephalitis virus; LC-MS: liquid
chromatography-mass spectrometry; moi: multiplicity of infection; VDAC:
voltage-dependent anion channels protein
Acknowledgements
The authors would especially like to thank Dr. Yusong Ruan, State Key
Laboratory of Biomembrane and Membrane Biotechnology, Institute of
Zoology, Chinese Academy of Sciences, for technical support for 2-DE and
LC-MS/MS analysis. This work is supported by Natural Science Foundation of
China (30600526, 30470091).
Author details
1Department of Microbiology, the Fourth Military Medical University, Xi’an,
Shaanxi, 710032, PR China.
2Department of Biopharmaceutics, School of
Pharmacy, the Fourth Military Medical University, Xi’an, Shaanxi, 710032, PR
China.
Authors’ contributions
TD and JR conceived the study and drafted the manuscript. TD carried out
the chemical mutation on BHK-21 cells. WZ did RT-PCR. JR carried out IFA,
plaque formation assay, flow cytometry, and 2-DE. TD and JR did
bioinformatic analysis. WM and JR proofread the manuscript. All authors
read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 23 October 2010 Accepted: 14 March 2011
Published: 14 March 2011
References
1. Tsai TF: New initiatives for the control of Japanese encephalitis by
vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15
October 1998. Vaccine 2000, 18(Suppl 2):1-25.
2. Solomon T: Control of Japanese encephalitis - within our grasp? New Eng
J Med 2006, 355:869-871.
3. Okada SF, O’Neal WK, Huang P, Nicholas RA, Ostrowski LE, Craigen WJ,
Paul WS, Moore PS, Karabatsos N, Flood SP, Yamada S, Jackson T, Tsai TF:
Outbreak of Japanese encephalitis on the island of Saipan. J Infect Dis
1993, 167:1053-1058.
4. Igarashi A, Tanaka M, Morita K, Takasu T, Ahmed A, Ahmed A, Akram DS,
Waqar MA: Detection of West Nile and Japanese encephalitis viral
genome sequences in cerebrospinal fluid from acute encephalitis cases
in Karachi, Pakistan. Microbiol Immunol 1994, 38:827-830.
5. Hanna JN, Ritchie SA, Phillips DA, Lee JM, Hills SL, van den Hurk AF,
Pyke AT, Johansen CA, Mackenzie JS: Japanese encephalitis in north
Queensland, Australia, 1998. Med J Austra 1999, 170:533-536.
6. Heinz FX: Epitope mapping of flavivirus glycoproteins. Adv Virus Res 1986,
31:103-168.
7. McMinn PC: The molecular basis of virulence of the encephalitogenic
flaviviruses. J Gen Virol 1997, 78:2711-2722.
8. Wu KP, Wu CW, Tsao YP, Kuo TW, Lou YC, Lin CW, Wu SC, Cheng JW:
Structural basis of a flavivirus recognized by its neutralizing antibody:
solution structure of the domain III of Japanese encephalitis virus
envelope protein. J Biol Chem 2003, 278:46007-46013.
9. Mackenzie JS, Gubler DJ, Petersen LR: Emerging flaviviruses: the spread
and resurgence of Japanese encephalitis, West Nile and dengue viruses.
Nat Med 2004, 10(12 Suppl):S98-109.
10. Kimura T, Kimura-Kuroda J, Nagashima K, Yasui K: Analysis of virus-cell
binding characteristics on the determination of Japanese encephalitis
virus susceptibility. Arch Virol 1994, 139:239-251.
11. Boonsanay V, Smith DR: Entry into and production of the Japanese
encephalitis virus from C6/36 cells. Intervirology 2007, 50:85-92.
12. Das S, Laxminarayana SV, Chandra N, Ravi V, Desai A: Heat shock protein
70 on Neuro2a cells is a putative receptor for Japanese encephalitis
virus. Virology 2009, 385:47-57.
13. Haywood AM: Virus receptors: binding, adhesion strengthening, and
changes in viral structure. J Virol 1994, 68:1-5.
14. Bradley KA, Mogridge J, Mourez M, Collier RJ, Young JA: Identification of
the cellular receptor for anthrax toxin. Nature 2001, 414(6860):225-229.
15. Nitayaphan S, Grant JA, Chang GJ, Trent DW: Nucleotide sequence of the
virulent SA-14 strain of Japanese encephalitis virus and its attenuated
vaccine derivative, SA-14-14-2. Virology 1990, 177:541-552.
16. Ren JP, Ding TB, Zhang W, Song JH, Ma WY: Does Japanese encephalitis
virus share the same cellular receptor with other mosquito-borne
flaviviruses on the C6/36 mosquito cells? Virol J 2007, 6:83.
17. Mirza SP, Halligan BD, Greene AS, Olivier M: Improved method for the
analysis of membrane proteins by mass spectrometry. Physiol Genomics
2007, 30:89-94.
18. Gerke V, Moss SE: Annexins: from structure to function. Physiol Rev 2002,
82:331-371.
19. Flower RJ, Rothwell NJ: Lipocortin-1: cellular mechanisms and clinical
relevance. Trends Pharmacol Sci 1994, 15:71-76.
20. Hwang HJ, Moon CH, Kim HG, Kim JY, Lee JM, Park JW, Chung DK:
Identification and functional analysis of salmon annexin 1 induced by a
virus infection in a fish cell line. J Virol 2007, 81:13816-13824.
21. Raynor CM, Wright JF, Waisman DM, Pryzdial EL: Annexin II enhances
cytomegalovirus binding and fusion to phospholipids membranes.
Biochem 1999, 38:5089-5095.
22. Malhotra R, Ward M, Bright H, Priest R, Foster MR, Hurle M, Blair E, Bird M:
Isolation and characterization of potential respiratory syncytial virus
receptor(s) on epithelial cells. Microbes Infect 2003, 5:123-133.
23. Ma G, Greenwell-Wild T, Lei K, Jin W, Swisher J, Hardegen N, Wild CT,
Wahl SM: Secretory leukocyte protease inhibitor binds to annexin II, a
cofactor for macrophage HIV-1 infection. J Exp Med 2004,
200:1337-1346.
24. Ryzhova EV, Vos RM, Albright AV, Harrist AV, Harvey T, Gonzalez-Scarano F:
Annexin 2: a novel human immunodeficiency virus type 1 Gag binding
protein involved in replication in monocyte-derived macrophages. J Virol
2006, 80:2694-2704.
25. Hodge T, Colombini M: Regulation of metabolite flux through voltage-
gating of VDAC channels. J Membr Biol 1997, 157:271-279.
26. Rostovtseva T, Colombini M: VDAC channels mediate and gate the flow
of ATP: implications for the regulation of mitochondrial function. Biophys
J 1997, 72:1954-1962.
27. Yu WH, Forte M: Is there VDAC in cell compartments other than the
mitochondria? J Bioenerg Biomembr 1996, 28:93-100.
28. Yu WH, Wolfgang W, Forte M: Subcellular localization of human voltage-
dependent anion channel isoforms. J Biol Chem 1995, 270:13998-14006.
29. Okada SF, O’Neal WK, Huang P, Nicholas RA, Ostrowski LE, Craigen WJ,
Lazarowski ER, Boucher RC: Voltage-dependent anion channel-1 (VDAC-1)
contributes to ATP release and cell volume regulation in murine cells. J
Gen Physiol 2004, 124:513-526.
30. Baker MA, Lane DJ, Ly JD, De Pinto V, Lawen A: VDAC1 is a transplasma
membrane NADH-ferricyanide reductase. J Biol Chem 2004,
279:4811-4819.
31. Vander Heiden MG, Li XX, Gottleib E, Hill RB, Thompson CB, Colombini M:
Bcl-xL promotes the open configuration of the voltage-dependent anion
channel and metabolite passage through the outer mitochondrial
membrane. J Biol Chem 2001, 276:19414-19419.
32. Sieczkarski SB, Whittaker GR: Viral entry. Curr Top Microbiol Immunol 2004,
285:1-23.
33. Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H:
Human P-selectin glycoprotein ligand-1 is a functional receptor for
enterovirus 71. Nat Med 2009, 15:794-797.
34. Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S:
Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med
2009, 15:798-801.
35. Smith AE, Helenius A: How viruses entry animal cells. Science 2004,
304(5668):237-242.
doi:10.1186/1743-422X-8-115
Cite this article as: Ding et al.: Identification of a mutated BHK-21 cell
line that became less susceptible to Japanese encephalitis virus
infection. Virology Journal 2011 8:115.
Ding et al. Virology Journal 2011, 8:115
http://www.virologyj.com/content/8/1/115
Page 7 of 7